title: Evaluation of a 4-steps-1-day whole body challenge protocol for the diagnosis of occupational asthma due to diisocyanates.
abstract: Inhalative challenges are important in the diagnosis of occupational asthma due to diisocyanates. As existing protocols are time-consuming and costly, it was the aim of this study to develop a short duration whole body exposure protocol. Ninety three subjects with suspected occupational diisocyanate-induced asthma and verified current or previous occupational exposure to diisocyanates and ten control subjects without diisocyanate exposure but with bronchial hyperresponsiveness were investigated. After baseline examination on the first day, subjects underwent a standardized whole body multiple-steps-1-day challenge with exposures of up to four times 30 min to concentrations of 5, 10, 20, and 30 ppb of the dominant diisocyanate used at work on the second day. Common spirometric and body plethysmographic parameters were used as positivity criteria. Overall, 14 subjects demonstrated a positive diisocyanate challenge, 19 were considered doubtful, and 60 were negative. All controls had negative challenges. Positive reactions occurred during the challenge (n = 10) or during follow-up (n = 4). Eight subjects showed >40 % fall of FEV1. These severe reactions occurred after 5 ppb (n = 2) or 10 ppb (n = 3), while isolated late reactions after 2 h of follow-up were not observed. Multivariate analysis showed an association between a positive challenge and both the degree of previous occupational exposure and the presence of baseline bronchial hyperresponsiveness. In summary, the proposed 4-steps-1-day diisocyanate challenge protocol induced pronounced bronchial reactions in a small number of subjects. As these reactions were more likely to occur after low concentrations, it is recommended to shift the initial concentration/dose step to lower exposures.
authors.affiliation: Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University (IPA), Bürkle-de-la-Camp-Platz 1, 44789, Bochum, Germany.
authors.forename: L
authors.initials: L
authors.lastname: Scheidler
authors.forename: K
authors.initials: K
authors.lastname: Sucker
authors.forename: D
authors.initials: D
authors.lastname: Taeger
authors.forename: V
authors.initials: V
authors.lastname: van Kampen
authors.forename: E
authors.initials: E
authors.lastname: Heinze
authors.forename: B
authors.initials: B
authors.lastname: Marczynski
authors.forename: C
authors.initials: C
authors.lastname: Monsé
authors.forename: T
authors.initials: T
authors.lastname: Brüning
authors.forename: R
authors.initials: R
authors.lastname: Merget
mesh_terms: D000328:Adult; D000368:Aged; D001249:Asthma / Q000139:chemically induced* / Q000175:diagnosis*; D016535:Bronchial Hyperreactivity; D001985:Bronchial Provocation Tests; D005260:Female; D006801:Humans; D017953:Isocyanates / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009784:Occupational Diseases / Q000139:chemically induced / Q000175:diagnosis*; D016273:Occupational Exposure; D011014:Pneumonia / Q000175:diagnosis; D015272:Pulmonary Medicine / Q000379:methods; D012129:Respiratory Function Tests; D012907:Smoking; D013147:Spirometry / Q000379:methods; D013997:Time Factors; D055815:Young Adult
chemical_list: D017953:Isocyanates